SERRANO-JAEN, Liliana et al. Dermatofitosis diseminada crónica asociada a fagocitosis deficiente tratada con antimicóticos e inmunoestimulación fagocitaria. Gac. Méd. Méx [online].
2006,
vol.142, n.5, pp. 415-417.
ISSN 0016-3813.
|
|
|
1. Akiba H, Motoki Y, Satoh M, Iwatsuki K, Kaneko F. Recalcitrant trichophytic granuloma associated with NK–cell deficiency in a SLE patient treated with cortlcosterold. Eur J Dermatol. 2001; 11:58–62. [ Links ] 2. Kalibala S. Skin conditions common to people with HIV infection or AIDS. AIDS Action 1990; 10:2–3. [ Links ] 3. Porro MA, Yoshioka MCN, Kaminski SK, Palmeira MC, Fischman O, Alchorne MMA. Disseminated dermatophytosis caused by Microsporum gypseum In two patients with the acquired immunodeficiency syndrome. Mycopathologia 1997; 137:9–12. [ Links ] 4. Huntley AC. The cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1982; 7:427–455. [ Links ] 5. Radentz WH. Opportunistic fungal infections in immunocompromlsed hosts. J Am Acad Dermatol 1989; 20:989–1003. [ Links ] 6. Baehner RL, Bocker LA, Davis J. Biochemical basis of nltroblue tetrazollum reduction in normal human and chronic granulomatous disease polimorphonuclear leukocyte. Blood 1976; 48:309–313. [ Links ] 7. Kaminsky G. Kaminski's Dermatophytes Scheme, http://www.mycology.adelalde.edu [ Links ] 8. Rubio–Calvo MC, GN–Tomas J, Ruesca RB. Valoración in vitro de la sensibilidad a los antifúngicos. Rev Iberoam Micol 1996; 13:S60–S63. [ Links ] 9. Busquet J, Lockey RF, Manning HJ (guest editors). WHO Position paper. Allergen immunotherapy: therapeutic vaccines on allergic diseases. Allegy 1998; 53(suppl 1):1 –42. [ Links ] 10. Doncker (de) P, Gupta AK, Marynissen G, Stoffels P, Hereman A. Itraconazole pulse therapy for onychomycosis and dermatomycoses: An overview. J Am Acad Dermatol 1997; 37:969–974. [ Links ] 11. Burkhart CN, Chang H, Gottwald L. Tinea corporis in human immunodeficiency virus–positive patients: case report and assessment of oral therapy. Int J Dermatol 2003; 42:839–843. [ Links ] 12. Squeo RF, Beer R, Silvers D, Weitzman I, Grossman M. Invasive Trichophyton rubrum resembling blastomycosis infection in the immunocompromised host. J Am Acad Dermatol. 1998; 39:379–380. [ Links ] 13. Roilides E, Lyman CA, Panagopoulou P, Chanock S. Immunomodulation of invasive fungal infections. Infec Dis Clin North Am 2003; 17:193:219. [ Links ] 14. Bjorksten B. Evidence of problotics in prevention of allergy and asthma. Curr Drugs Targets Inflamm Allergy 2005; 4:599–604. [ Links ] 15. Kilpimaa J, Van de Casteele T, Jokinen I, Mappes J, Alatalo RV. Genetic and envlromental variation in antibody and T–cell mediated responses in great tit. Int J Org Evolution 2005; 59:2483–2489. [ Links ] 16. Wright RJ. Stress and atoplc disorders. J Allergy Clin Immunol 2005; 116:1301–1306. [ Links ] 17. Chapman MD. Asthma in the third world: can enviromental intervention improve childhood asthma in U. S. Inner cities? Ann Allergy Asthma Immunol 2005; 95:496–497. [ Links ] 18. Rovere–Querini P, Manfredi AA, Sabbadini MG. Enviromental adyuvants apoptosls and the censorship over autoimmunity. Autoimmun Rev 2005;4:555–560. [ Links ] 19. Méndez–Tovar LJ, Serrano–Jaén L, Almeida–Arvizu VM. Cefotaxima más amikacina asociadas a inmunomodulación en el tratamiento de actinomicetoma resistente a tratamiento convencional. Gac Med Mex 1999; 135:517–521. [ Links ] |
